Zaragoza, Spain

Juan Ignacio Aguiló Anento

 


Loading Chart...

Title: Juan Ignacio Aguiló Anento: Innovator in Tuberculosis Research

Introduction

Juan Ignacio Aguiló Anento is an inventor based in Zaragoza, Spain. He has made significant contributions to the field of tuberculosis research. Although he currently holds no granted patents, his work is noteworthy for its potential impact on public health.

Latest Patent Applications

Juan Ignacio Aguiló Anento has submitted several patent applications, including:

- **Compositions for Use as a Prophylactic Agent to Those at Risk of Infection of Tuberculosis, or as Secondary Agents for Treating Infected Tuberculosis Patients**. This invention refers to a freeze-dried composition consisting of an isolated microorganism belonging to the tuberculosis complex. It is characterized by a PhoP− phenotype due to the inactivation of the Rv0757 gene and the deletion of a second gene, Rv2930 (fadD26), which prevents PDIM production. The composition includes sucrose and sodium glutamate as stabilizers or excipients. The invention also covers the reconstituted composition obtained by adding sterilized water for injection to the freeze-dried composition, particularly for use as a prophylactic agent for those at risk of tuberculosis infection or as secondary agents for treating infected patients.

Conclusion

Juan Ignacio Aguiló Anento's work in tuberculosis research highlights his commitment to addressing significant health challenges. His innovative approaches may pave the way for future advancements in the prevention and treatment of tuberculosis.

This text is generated by artificial intelligence and may not be accurate.
Loading…